You can buy or sell RTTR and other stocks, options, ETFs, and crypto commission-free!
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. Read More The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.
Los Angeles, California
52 Week High
52 Week Low
Expected Nov 8, After Hours